Thrivent Financial for Lutherans’s Acceleron Pharma XLRN Stock Holding History

Thrivent Financial for Lutherans’s Portfolio XLRN Stock Details XLRN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-11,009	Closed	-$1.38M	–	2514
2021 Q2	$1.38M	Hold	11,009	–	–	﹤0.01%	1648
2021 Q1	$1.49M	Sell	11,009 -1,633	-13%	-$211K	﹤0.01%	1598
2020 Q4	$1.62M	Hold	12,642	–	–	﹤0.01%	1451
2020 Q3	$1.42M	Sell	12,642 -9	-0.1%	-$896	﹤0.01%	1362
2020 Q2	$1.21M	Hold	12,651	–	–	﹤0.01%	1373
2020 Q1	$1.14M	Buy	+12,651	New	+$983K	﹤0.01%	1225
2018 Q3	–	Sell	-28,578	Closed	-$1.39M	–	2038
2018 Q2	$1.39M	Buy	+28,578	New	+$1.04M	﹤0.01%	1060
2017 Q2	–	Sell	-26,920	Closed	-$713K	–	2093
2017 Q1	$713K	Buy	26,920 +9,440	+54%	+$249K	﹤0.01%	1354
2016 Q4	$446K	Hold	17,480	–	–	﹤0.01%	1559
2016 Q3	$633K	Buy	+17,480	New	+$579K	﹤0.01%	1348
2016 Q1	–	Sell	-37,630	Closed	-$1.83M	–	2040
2015 Q4	$1.83M	Buy	37,630 +7,210	+24%	+$259K	0.01%	877
2015 Q3	$757K	Sell	30,420 -6,850	-18%	-$206K	﹤0.01%	1044
2015 Q2	$1.18M	Hold	37,270	–	–	0.01%	780
2015 Q1	$1.42M	Sell	37,270 -30	-0.1%	-$1.19K	0.01%	764
2014 Q4	$1.45M	Sell	37,300 -3,000	-7%	-$105K	0.01%	763
2014 Q3	$1.22M	Buy	+40,300	New	+$1.14M	0.01%	817

Other funds holding XLRN

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

DGM

Darwin Global Management St. Helier, Jersey $3.77B AUM 307.72% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return

Alkeon Capital Management New York $59.5B AUM 51.63% 1-Year Est. Return

Thrivent Financial for Lutherans's XLRN Position: Q3 2021 in Review

Thrivent Financial for Lutherans sold out of Acceleron Pharma (XLRN) in Q3 2021, closing a stake of 11,009 shares — an estimated $1.38M sold.

Thrivent Financial for Lutherans first reported a position in XLRN in Q3 2014 and held it in 16 quarters. The position peaked at $1.83M in Q4 2015. 330 funds tracked by Wall St. Rank hold XLRN as of Q3 2021.

Thrivent Financial for Lutherans reported no remaining Acceleron Pharma position as of Q3 2021 after selling out during the quarter.
Thrivent Financial for Lutherans sold 11,009 Acceleron Pharma shares in Q3 2021, an estimated $1.38M.
Thrivent Financial for Lutherans first reported a position in Acceleron Pharma in Q3 2014 and held it in 16 quarters.
Thrivent Financial for Lutherans's Acceleron Pharma position peaked at $1.83M in Q4 2015.
330 funds tracked by Wall St. Rank held Acceleron Pharma as of Q3 2021.

Based on Thrivent Financial for Lutherans's 13F filing for Q3 2021, filed 15 Nov 2021.